RAD51AP1 and pancreatic adenocarcinoma: Increased RAD51AP1 expression also indicated high-grade differentiation in stomach and esophageal carcinoma (STES), kidney renal papillary cell carcinoma (KIRP), and UCEC, higher T stage in pancreatic adenocarcinoma (PAAD) and uterine carcinosarcoma (UCS), higher M stage in LGG, and MESO, and higher TNM stage in UCEC and thyroid carcinoma (THCA) (Supplementary Figures S1C–F).